Professor, Chemistry and Biochemistry
Psychiatry and Biobehavioral Sciences
Member, Biochemistry, Biophysics & Structural Biology GPB Home Area
Brain Research Institute
California NanoSystems Institute
Molecular Pharmacology GPB Home Area
Neuroscience GPB Home Area
Senior Research Scientist, Hatos Center for Neuropharmacology
Office Phone Number: 310-794-9421
Mailing Address:Neuroscience Research Building
635 Charles E. Young Dr S, Box 957332
Los Angeles, CA 90095
Office Address:Department of Psychiatry and Biobehavioral Sciences
Dr. Andrews is Professor of Psychiatry & Biobehavioral Sciences and Chemistry & Biochemistry at the University of California, Los Angeles. She is a member of the Semel Institute for Neuroscience & Human Behavior, the Hatos Center for Neuropharmacology, and the California NanoSystems Institute. Andrews received a B.S. from the Pennsylvania State University and a Ph.D. in Chemistry as a U.S. Department of Education Fellow working at the National Institute of Mental Health, where she was later a postdoctoral fellow and senior staff fellow. At the NIMH, Andrews discovered and characterized a novel serotonin neurotoxin, 2’-NH2 -MPTP. She was a member of the team that made and characterized the first serotonin transporter-deficient mouse model.
Andrews is the recipient of an NIH Director’s Transformative Research Award. She received a California Neurotechnologies Research Award, a NARSAD Independent Investigator Award, an American Parkinson’s Disease Association Research Award, an Eli Lily Outstanding Young Analytical Chemist Award, and an NIH Fellows Award for Research Excellence. She is a Fellow of the American College of Neuropsychopharmacology and President of the International Society for Serotonin Research. Andrews was invited to the White House for President Obama’s announcement of the BRAIN Initiative, which she was instrumental in shaping.
At UCLA, Andrews leads efforts in basic and translational research on anxiety and depression, at the nexus of neuroscience and nanoscience. Andrews’ interdisciplinary team of neuroscientists, chemists, and engineers seeks to understand serotonergic encoding of emotionally salient information related to anxiety, mood, and stress responsiveness. Serotonin neurotransmission is studied in mouse models and psychiatric patient populations. Genetics, pharmacology, and developmental timing are used to investigate the etiology and treatment of anxiety and mood disorders, and to advance personalized predictive medicine. Electronic field-effect transistor sensors, microelectrode voltammetry, and microdialysis methods are developed to investigate serotonin transmission at high spatial, temporal, and chemical resolution in vivo .